Skip to main content

Grygiel Nancy A.'s Form 4 filing

Amgen Inc (AMGN) · filed Dec 4, 2023

Accession no.
0001127602-23-028779
Filed
Dec 4, 2023
Trade date
Dec 4, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $572.3K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grygiel Nancy A.CIK 0001816414Officer (SVP & CCO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 4, 2023Common StockSSaleDisposed−2,096$273.03−$572,270.8810,874Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)